Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice

Cerebral cavernous malformation (CCM) is a disease of the central nervous system causing hemorrhage-prone multiple lumen vascular malformations and very severe neurological consequences. At present, the only recommended treatment of CCM is surgical. Because surgery is often not applicable, pharmacol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Proc Natl Acad Sci U S A
Autors principals: Bravi, Luca, Rudini, Noemi, Cuttano, Roberto, Giampietro, Costanza, Maddaluno, Luigi, Ferrarini, Luca, Adams, Ralf H., Corada, Monica, Boulday, Gwenola, Tournier-Lasserve, Elizabeth, Dejana, Elisabetta, Lampugnani, Maria Grazia
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2015
Matèries:
Biological Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4500248/
https://ncbi.nlm.nih.gov/pubmed/26109568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1501352112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars